Skip to main content

Elderly

1
Pipeline Programs
7
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
Trospium ChloridePhase 41 trial
Active Trials
NCT00863551Completed12Est. Aug 2009
Abbott
AbbottABBOTT PARK, IL
2 programs
Divalproex Sodium Extended-Release TabletsN/A1 trial
Ensure PlusN/A1 trial
Active Trials
NCT00318929Completed14Est. Jan 2008
NCT00933153Completed91Est. Oct 2011
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Geriatric home visit and Action PlanN/A1 trial
Active Trials
NCT00217113Completed100Est. Aug 2007
Coordination Pharmaceuticals
1 program
Virtual Reality TrainingN/A1 trial
Active Trials
NCT01741402Completed32Est. Feb 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbVieTrospium Chloride
Coordination PharmaceuticalsVirtual Reality Training
AbbottEnsure Plus
AbbottDivalproex Sodium Extended-Release Tablets
Human BioSciencesGeriatric home visit and Action Plan

Clinical Trials (5)

Total enrollment: 249 patients across 5 trials

NCT00863551AbbVieTrospium Chloride

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Start: Apr 2009Est. completion: Aug 200912 patients
Phase 4Completed
NCT01741402Coordination PharmaceuticalsVirtual Reality Training

Effects of Training in a Virtual Environment in Healthy Elderly

Start: Feb 2010Est. completion: Feb 201432 patients
N/ACompleted
NCT00933153AbbottEnsure Plus

Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Population

Start: Oct 2009Est. completion: Oct 201191 patients
N/ACompleted
NCT00318929AbbottDivalproex Sodium Extended-Release Tablets

Tolerability and Efficacy of Depakote-extended Release in the Elderly

Start: Apr 2006Est. completion: Jan 200814 patients
N/ACompleted
NCT00217113Human BioSciencesGeriatric home visit and Action Plan

An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly

Start: Sep 2005Est. completion: Aug 2007100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.